ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.
Clinical trial NCT00040625 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00040625
- Sponsor
- Eli Lilly and Company
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.